Addyi 100MG Tablets

Addyi (Flibanserin) | Prescription Treatment for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

Addyi is an FDA-approved prescription medication specifically developed to treat acquired, generalized Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. It is designed to help improve low sexual desire that causes distress or interpersonal difficulty and is not due to a medical condition, mental disorder, relationship issue, or the effects of drugs or alcohol.

 Key Information:

• Contains flibanserin, a non-hormonal treatment that works on brain neurotransmitters involved in sexual desire

• Intended only for premenopausal women with acquired, generalized HSDD

• Not recommended for use in postmenopausal women or men

• Must be prescribed and monitored by a licensed healthcare provider

• Alcohol consumption must be avoided while using Addyi due to potential severe side effects

 Not for:

• Women who have undergone menopause

• Men of any age

• Individuals with underlying conditions causing low libido